Live Breaking News & Updates on Cardiff Oncology Company Profile

Stay updated with breaking news from Cardiff oncology company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

HC Wainwright Reiterates "Buy" Rating for Cardiff Oncology (NASDAQ:CRDF)

HC Wainwright Reiterates "Buy" Rating for Cardiff Oncology (NASDAQ:CRDF)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United States , Piper Sandler , Cardiff Oncology Company Profile , Blair William Co , Callan Capital , Cardiff Oncology Inc , Cardiff Oncology , Free Report , Get Free Report , Polo Like Kinase , Cardiff Oncology Daily ,

Cardiff Oncology's (CRDF) "Buy" Rating Reiterated at HC Wainwright

Cardiff Oncology's (CRDF) "Buy" Rating Reiterated at HC Wainwright
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Piper Sandler , Cardiff Oncology Company Profile , Callan Capital , Cardiff Oncology Inc , Cardiff Oncology , Free Report , Oncology Stock Down , Get Free Report , Polo Like Kinase , Cardiff Oncology Daily ,

Cardiff Oncology (CRDF) Scheduled to Post Earnings on Thursday

Cardiff Oncology (NASDAQ:CRDF – Get Free Report) will be posting its quarterly earnings results after the market closes on Thursday, May 2nd. Analysts expect Cardiff Oncology to post earnings of ($0.25) per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link. Cardiff Oncology (NASDAQ:CRDF […] ....

United States , Piper Sandler , Cardiff Oncology Company Profile , Cardiff Oncology Inc , Cardiff Oncology , Get Free Report , Oncology Stock Down , Polo Like Kinase , Cardiff Oncology Daily , Nasdaq Crdf ,

Insider Buying: Cardiff Oncology, Inc. (NASDAQ:CRDF) Director Acquires 30,000 Shares of Stock

Insider Buying: Cardiff Oncology, Inc. (NASDAQ:CRDF) Director Acquires 30,000 Shares of Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United States , Dimensional Fund Advisors , Cardiff Oncology Inc , Cardiff Oncology Company Profile , Walleye Capital , Topco Ltd , Pricet Rowe Associates Inc , America Corp , Cardiff Oncology , Get Free Report , Director Gary , Fund Advisors , Polo Like Kinase , Cardiff Oncology Daily ,

Cardiff Oncology, Inc. (NASDAQ:CRDF) Short Interest Down 9.4% in November

Cardiff Oncology, Inc. (NASDAQ:CRDF – Get Free Report) was the recipient of a significant decrease in short interest in November. As of November 30th, there was short interest totalling 1,450,000 shares, a decrease of 9.4% from the November 15th total of 1,600,000 shares. Based on an average daily trading volume, of 688,500 shares, the short-interest […] ....

United States , Renaissance Technologies , Cardiff Oncology Inc , Cardiff Oncology Company Profile , Blackrock Inc , Vanguard Group Inc , Citigroup Inc , Cardiff Oncology , Get Free Report , Street Corp , Polo Like Kinase , Cardiff Oncology Daily , Nasdaq Crdf ,